Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues
The presence of Epstein-Barr virus (EBV) in the tumor cells of some EBV-associated malignancies may facilitate selective killing of these tumor cells. We show that treatment of an EBV(+) Burkitt's lymphoma cell line with 5-azacytidine led to a dose-dependent induction of EBV lytic antigen expression...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
2001
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90604/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11408227/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.7.2082-2091.2001 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
